Robella, M.; Berchialla, P.; Borsano, A.; Cinquegrana, A.; Ilari Civit, A.; De Simone, M.; Vaira, M.
Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases. Int. J. Environ. Res. Public Health 2021, 18, 5656.
https://doi.org/10.3390/ijerph18115656
AMA Style
Robella M, Berchialla P, Borsano A, Cinquegrana A, Ilari Civit A, De Simone M, Vaira M.
Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases. International Journal of Environmental Research and Public Health. 2021; 18(11):5656.
https://doi.org/10.3390/ijerph18115656
Chicago/Turabian Style
Robella, Manuela, Paola Berchialla, Alice Borsano, Armando Cinquegrana, Alba Ilari Civit, Michele De Simone, and Marco Vaira.
2021. "Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases" International Journal of Environmental Research and Public Health 18, no. 11: 5656.
https://doi.org/10.3390/ijerph18115656
APA Style
Robella, M., Berchialla, P., Borsano, A., Cinquegrana, A., Ilari Civit, A., De Simone, M., & Vaira, M.
(2021). Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases. International Journal of Environmental Research and Public Health, 18(11), 5656.
https://doi.org/10.3390/ijerph18115656